US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist

48.190
-0.040-0.08%

Close Jan 2 16:00 ET

48.280
+0.090+0.19%

Pre 04:03 ET

120.82BMarket Cap26.15P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sanofi Q3 2024 Earnings Date

Currency：USDOct 25, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	14.11B	15.76B	+1.66B
Beat Est.	+11.53%	+17.42%	+11.73%
EPS	1.12	1.25	+0.13
Beat Est.	+5.50%	+17.89%	+11.55%

Analyst Rating

Buy

Dec 31, 2024

Sanofi Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Apr 24, 2025	2025/Q1	-- / 10.960B	--
Jan 30, 2025	2024/Q4	-- / 10.982B	--
Oct 25, 2024	2024/Q3	13.438B / 12.670B	--
Jul 25, 2024	2024/Q2	10.745B / 10.377B	--
Apr 25, 2024	2024/Q1	10.464B / 10.208B	--

DatePeriodRevenue/EstimateEarnings Call

Apr 24, 20252025/Q1-- / 10.960B--

Jan 30, 20252024/Q4-- / 10.982B--

Oct 25, 20242024/Q313.438B / 12.670B--

Jul 25, 20242024/Q210.745B / 10.377B--

Apr 25, 20242024/Q110.464B / 10.208B--

Unlock Free Earnings Estimates

Open Account

Sanofi Earnings Reports

6-K: 15.7% Sales Growth Boosted by Earlier-Than-Anticipated Vaccine Sales; 2024 Business Eps Guidance Raised Due to Strong Business Performance

Oct 25, 2024 12:42 ET

6-K: Sanofi Reports Strong Second Quarter Results with 10% Sales Growth; 2024 Guidance Upgraded

Jul 25, 2024 11:48 ET

6-K: 2024 Half-Year Financial Report

Jul 25, 2024 10:29 ET

Sanofi | 6-K: Colletion of Recent Announcements

May 2, 2024 15:56 ET

Trending US Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 31, 2024

Buy

Buy
66.67%
Hold
33.33%
Sell
0.00%

Price Target

No Data

Investment Theme

Infectious Disease

Intraday+0.03%